Schmidt & Clark, LLP, is currently investigating potential lawsuits for men who suffered a heart attack after using Depo-Testosterone, a new testosterone replacement therapy (TRT) product. In recent months, a pair of credible scientific studies have identified a significantly increased risk of cardiovascular events such as heart attack in users of TRT supplements like Depo-Testosterone.
Free Depo-Testosterone Heart Attack Lawsuit Evaluation: If you or a loved one suffered a heart attack after using Depo-Testosterone, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Depo-Testosterone and we can help.
Lawsuits Allege Heart Attacks Caused by Testosterone Booster
Five men are suing the manufacturer of AndroGel (a TRT supplement in the same class as Depo-Testosterone), alleging the company hid information that using the drug could increase the risk of heart attack, stroke and sudden death. The lawsuits were filed just four days after the FDA kicked off an investigation into the safety of testosterone boosters. The agency noted the results of a pair of recent studies that linked testosterone treatments to heart attack, stroke and death as the reason for its investigation.
The plaintiffs ranged in age from 50 to 63. Three said they had a heart attack after taking testosterone; one claims to have suffered a stroke, and the other says he had an ischemic attack, or ‘mini-stroke.’ According to the plaintiffs, AndroGel’s manufacturer aggressively marketed the product directly to consumers, telling them that natural aging processes such as weight gain, lowered libido, and slumping energy are all symptoms of low testosterone, and can be treated with the use of AndroGel.
“What consumers received, however, were not safe drugs, but a product which causes life-threatening problems, including strokes and heart attacks,” according to the testosterone lawsuits. Additionally, the manufacturers “purposefully downplayed, understated and outright ignored” those risks in its marketing campaign, the suits contend.
Depo-Testosterone Heart Attack Medical Studies
The short-term benefits of TRT products like Depo-Testosterone were considered favorable, until recently when two studies determined that users of these drugs were far more likely to suffer cardiovascular complications compared to non-users.
The first study, which was published in the Journal of the American Medical Association in November of 2013, indicated that older men who underwent testosterone treatment for a period of 3 years were up to 30% more likely to have a heart attack, stroke or die from any cause compared to similar-aged men who did not take testosterone.
A second study, published on Jan. 29, 2014, found that TRT boosters like Depo-Testosterone doubled the risk of heart attack in males over the age of 65, and nearly tripled the risk in younger men with a pre-existing history of heart disease. The new study was led by researchers at UCLA, and published in the medical journal PLOS ONE.
Do I Have a Depo-Testosterone Heart Attack Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Depo-Testosterone Lawsuits. We are handling individual litigation nationwide and currently accepting new Depo-Testosterone Heart Attack cases in all 50 states.
Free Depo-Testosterone Heart Attack Lawsuit Evaluation: If you or a loved one suffered a heart attack after taking Depo-Testosterone, you should contact our law firm immediately. You may be entitled to compensation by filing a Depo-Testosterone Heart Attack Suit and we can help.